Literature DB >> 2569441

Role of cloned virulence factors (mannose-resistant haemagglutination, mannose-resistant adhesions) from uropathogenic Escherichia coli strains in the release of inflammatory mediators from neutrophils and mast cells.

W König1, B König, J Scheffer, J Hacker, W Goebel.   

Abstract

Genetically cloned E. coli strains expressing cloned virulence factors were studied with regard to their capability to induce inflammatory mediator release from various target cells. Among the strains were E. coli strains with mannose-resistant haemagglutination (MRH+) and mannose-resistant adhesins, e.g. E. coli 536/21 pANN 801/4, E. coli 536/21 pANN 921 and E. coli 536/21 pANN 801-1. In comparison, E. coli 536/21, E. coli 536/21 pGB 30 int and E. coli K12, without and with mannose-sensitive haemagglutination (MSH +/-), and adhesins were studied. The properties of the various strains for human PMN with regard to adherence and phagocytosis, chemiluminescence, 5-lipoxygenase activation of arachidonic acid, leukotriene formation, granular enzyme release and release of histamine from rat mast cells were analysed. It is evident that the various biochemical processes of cell activation are dissociated events. The highest chemiluminescence response is obtained with strains expressing MSH+, P-MRH+ or S-MRH+; the presence of S-adhesins suppressed the response. Highest leukotriene formation is obtained with E. coli 536/21 pANN 801-4, while E. coli with MSH was inactive. The concomitant presence of haemolysin secretion enhanced mediator release significantly. Our data suggest a potent role for mannose-resistant haemagglutination (MRH), adhesins and haemolysin as virulence factors in inducing the release of inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569441      PMCID: PMC1385360     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Genetics and pathogenic role of Escherichia coli haemolysin.

Authors:  C Hughes; D Müller; J Hacker; W Goebel
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

3.  Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.

Authors:  E Blumenstock; K Jann
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

4.  Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates.

Authors:  B H Minshew; J Jorgensen; G W Counts; S Falkow
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

5.  Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.

Authors:  B Björkstén; B Kaijser
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

6.  Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.

Authors:  D J Evans; D G Evans; C Höhne; M A Noble; E V Haldane; H Lior; L S Young
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

7.  Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils.

Authors:  B A Macher; J C Klock
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

8.  Enhancement of mannose-mediated stimulation of human granulocytes by type 1 fimbriae aggregated with antibodies on Escherichia coli surfaces.

Authors:  A Perry; I Ofek; F J Silverblatt
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Mannose-sensitive interaction of Escherichia coli with human peripheral leukocytes in vitro.

Authors:  D F Mangan; I S Snyder
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

10.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  5 in total

1.  Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.

Authors:  P O'Hanley; G Lalonde; G Ji
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

2.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

3.  Roles of human peripheral blood leukocyte protein kinase C and G proteins in inflammatory mediator release by isogenic Escherichia coli strains.

Authors:  B König; W König
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Effects of adhesins from mannose-resistant Escherichia coli on mediator release from human lymphocytes, monocytes, and basophils and from polymorphonuclear granulocytes.

Authors:  Y Ventur; J Scheffer; J Hacker; W Goebel; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains.

Authors:  B König; W Schönfeld; J Scheffer; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.